Related Experiment Videos
Alpha2-plasmin-inhibitor deficiency (Miyasato disease)
Lancet (London, England)
|December 23, 1978
Summary
A patient with a bleeding disorder lacked alpha2-plasmin inhibitor, a key protein regulating blood clots. Treatment with an antiplasminic drug effectively reduced bleeding episodes, suggesting a new therapeutic target.
Area of Science:
- Hematology
- Molecular Biology
- Genetics
Background:
- A 25-year-old Japanese male presented with a lifelong hemorrhagic diathesis, including prolonged bleeding, ecchymoses, and spontaneous joint hemorrhages.
- Symptoms were partially alleviated by an antiplasminic drug, indicating a potential role for fibrinolysis in his condition.